Richard C. Malabre, the Senior Vice President and Chief Accounting Officer of Akebia Therapeutics, Inc. (NASDAQ:AKBA), ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

A combination treatment has shown promise for treating a rare blood disease, according to a clinical trial published in the ...

Red blood cell transfusions (RBCTs) are life-saving treatments for critically ill patients suffering from anemia, a condition ...

Metastatic breast cancer can come with many physical changes that can be noticeable and impact daily functioning, but there ...

Anemia during pregnancy is a common occurrence and often due to iron deficiency. It is a global public health problem, affecting an estimated 37 percent of pregnant individuals, according to the World ...

Red blood cell transfusions (RBCTs) are life-saving treatments for critically ill patients suffering from anemia, a condition ...

Iron deficiency may be linked to non-dialysis-dependent chronic kidney disease and mortality in patients without anemia, according to results of a nationwide cohort study.While iron is a key component ...

Research found that ibrutinib reduces red blood cell aggregation in patients with chronic lymphocytic leukemia (CLL), while ...

Thomas W. LeBlanc, MD, MA, discusses key clinical pearls for community oncologists in the treatment of anemia in patients with low-risk myelodysplastic syndromes (LR-MDS), including the importance of ...